RUNX3 and lip and oral cavity carcinoma: The increased RUNX3 gene expression in the most advanced tumor stage, stage IV, with bone invasion is consistent with our in vitro and in vivo data suggesting the oncogenic role of RUNX3 in oral cancer bone invasion.